SCGLY News and Press, Societe Generale ADR From 05/09/22

Strong results above analyst expectations. Positive tailwinds thanks to ALD. After the recent sell-off, we continue to see SocGen with a compelling valuation. For further details see: SocGen: We Reiterate Our Buy Rating

Societe Generale's strong 2021 momentum carried into Q1 2022, with reported underlying RoTE of 11.9%. The sale of Russian subsidiary Rosbank should result in a loss of tangible net asset value per share of about 2.42 EUR/share. However, the potential 915M EUR buyback could boost t...

Mixed results. Limited Russia exposure, HSBC is currently heavily investing in Asia with the wealth management being a key division to monitor. Concern on CET1, buyback suspended. Neutral rating. We prefer other banks such as SocGen and UBS Group AG. For further details see:...

The general rule is that the market always likes stability. In this sense, Macron's victory will likely be perceived positively by the market. Marine Le Pen promises a policy of protectionism, restrictions on migration and withdrawal from NATO. This will inevitably lead to conflicts w...

French bank Societe Generale (OTCPK:SCGLY)  to sell its stake in Rosbank and the Russian lender’s insurance subsidiaries to Interros Capital, a firm linked to billionaire Vladimir Potanin and  a previous shareholder of Rosbank - WSJ. The transaction would result in ...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Covestro AF (OTCMKTS: COVTY ): A leading polymer player with cheap multiples Altria (NYSE: MO ): Profit margins are expected to increase significantly this year Societe Generale (OTCMKTS: SCGLY ): Exc...

Limited Russia exposure. The French institute has enough capital buffer to sustain Russian margin loss. Lower cost of risk and strong results from ALD give this a buy with a TP at 30 euro per share. For further details see: SocGen: Time To Enter

Strong operating performance, low cost of risk and exceptional factors made 2021 the best year ever for Societe Generale. RoTE of 9.2% for Q4 was below the 10.2% achieved for the full year. I expect further deterioration in 2022 given expected cost of risk at below 30 bps (2021 13bps)...

SocGen continues to string together substantially better-than-expected quarters, with a fourth quarter that beat on almost every line that matters. The French Retail business seems to have more than stabilized, and initial results from the restructured GBIS segment have been encouragi...

Bank of the West disposal. Solid fundamentals and strong Q4 Results. Increased importance of ARVAL. For further details see: BNP Paribas: Everything Fully Priced In